Follow-The-Filings

Security · featured owners

SNDX Syndax Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 2.6%
  • $29M
  • 2 add 1 exit

SNDX (Syndax Pharmaceuticals Inc.) is held in 3 featured 13F books as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (2.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.6% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 2.6%
  2. Nathan Fischel Add 1.4%
  3. Torray Investment Partners Add 0.39%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Palo Alto Investors 2026 Q2 2.6% Hold 864,986 $19M History
Nathan Fischel - Dafna Capital Management 2026 Q2 1.4% Add +54.2% 335,255 $7M History
Torray Investment Partners 2026 Q2 0.39% Add +27.6% 133,835 $3M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 10,000 $234K History

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 19 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 1.01,2.03,3.02,9.01 Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01 Filing Doc
8-K 5.03 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Jul 8, 2026 Filing Doc
4 Period Jun 11, 2026 Filing Doc
4 Period Jun 1, 2026 · 2 forms Filing Doc
4 Period Feb 9, 2026 · 2 forms Filing Doc
4 Period Feb 4, 2026 · 9 forms Filing Doc
4 Period Dec 1, 2025 Filing Doc
4 Period Sep 8, 2025 Filing Doc
4 Period Aug 14, 2025 Filing Doc
4 Period Jul 31, 2025 Filing Doc
4 Period Jul 16, 2025 · 2 forms Filing Doc

Updated 21 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0M $23.68M $172.35M
Net income -$209.36M -$318.76M -$285.42M
Net margin * — -1346.1% -165.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $580.88M $603.06M $528.08M
Total non-current assets * $32M $121.76M $1.62M
Total assets $612.88M $724.82M $529.71M
Total current liabilities $58.1M $103.55M $120.12M
Total non-current liabilities $0.588M $333.14M $344.96M
Total equity $554.2M $288.12M $64.63M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$160.6M -$274.9M -$322.98M
Cash from investing $117.61M -$219.78M $290.04M
Cash from financing $264.13M $353.37M $13.68M
Net change in cash $221.14M -$141.31M -$19.27M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders